M. Carmody - Concepedia

Author

M. Carmody

Beaumont Hospital

Also Known As

C. Bergin, E. Kay, M CARMODY, M Carmody, M. CARMODY, M. Carmody, MARYBETH W. CARMODY, Marita Carmody, Michael Carmody

Publications

717

Citations

H-Index

Concepts

All Affiliations

Beaumont Hospital Charitable Infirmary Kerckhoff Klinik

About

M. Carmody is an author at Beaumont Hospital specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	253
2	Health Sciences	1	1	13
3	Allergy	1	1	32
4	Cell Biology	1	1	32
5	Hepatology	1	1	12

M. Carmody

Publications

537

Citations

H-Index

Page 1

	Year	Citations
Recurrent Glomerulonephritis in Renal Transplants: Fourteen Years' Experience Yvonne O’Meara, Andrew Green, M. Carmody, Nephrology Dialysis Transplantation	1989	69
Access to circulation by permanent arteriovenous fistula in regular dialysis treatment. J S Hanson, M. Carmody, Bruce Keogh, BMJ	1967	53
Pharmacokinetics of Amlodipine in Renal Impairment M. S. Laher, John G. Kelly, G. D. Doyle, Journal of Cardiovascular Pharmacology	1988	44
Glomerulonephritis after ventriculo-atrial shunt John P. Vella, M. Carmody, Emer Campbell, QJM Heart FailureMembranoproliferative GlomerulonephritisVentriculo-atrial ShuntGlomerulonephritisAverage 12.5	1995	38
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. J.G. Kelly, G. D. Doyle, M. Carmody, British Journal of Clinical Pharmacology Haemodialysis Plasma ClearanceDialysis TherapyPharmacotherapyPharmacokineticsRenal Function	1988	33
Production of Monoclonal Antibodies Specific for Platelet Activation Antigens and Their Use in Evaluating Platelet Function M. Carmody, Kenneth A. Ault, Jane Mitchell, Hybridoma Monoclonal Antibodies SpecificImmunologyBlood CellImmunotherapyPlatelet Activation Antigens	1990	32
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
Nephrotic syndrome in Hodgkins disease. Francine Walker, Sean O’Neill, M. Carmody, PubMed Glomerular DiseaseRenal PathologyPathologyHuman PathologyGlomerulonephritis	1983	28
Cutaneous abnormalities and metabolic disturbance of porphyrins in patients on maintenance haemodialysis Gillian Gibson, E. MCGINNITY, Paul McGrath, Clinical and Experimental Dermatology	1997	22

Page 1